Parallax Volatility Advisers’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-20,000
| Closed | -$9.34M | – | 1651 |
|
|
2025
Q4 | $9.34M | Hold |
20,000
| – | – | 0.02% | 488 |
|
|
2025
Q3 | $8.52M | Hold |
20,000
| – | – | 0.01% | 516 |
|
|
2025
Q2 | $7.66M | Sell |
20,000
-5,000
| -20% | -$1.8M | 0.02% | 509 |
|
|
2025
Q1 | $8.64M | Buy |
+25,000
| New | +$8.04M | 0.02% | 483 |
|
|
2024
Q2 | – | Sell |
-1,800
| Closed | -$600K | – | 2118 |
|
|
2024
Q1 | $600K | Sell |
1,800
-10,500
| -85% | -$3.21M | ﹤0.01% | 1355 |
|
|
2023
Q4 | $3.33M | Buy |
12,300
+10,800
| +720% | +$2.67M | 0.01% | 984 |
|
|
2023
Q3 | $369K | Buy |
1,500
+900
| +150% | +$246K | ﹤0.01% | 1680 |
|
|
2023
Q2 | $182K | Sell |
600
-6,300
| -91% | -$1.75M | ﹤0.01% | 1902 |
|
|
2023
Q1 | $1.82M | Sell |
6,900
-39,100
| -85% | -$9.93M | ﹤0.01% | 1262 |
|
|
2022
Q4 | $11M | Buy |
46,000
+5,700
| +14% | +$1.28M | 0.02% | 740 |
|
|
2022
Q3 | $7.41M | Buy |
40,300
+9,200
| +30% | +$1.83M | 0.01% | 868 |
|
|
2022
Q2 | $5.23M | Sell |
31,100
-9,300
| -23% | -$2M | 0.01% | 959 |
|
|
2022
Q1 | $10.1M | Buy |
40,400
+32,100
| +387% | +$8.06M | 0.01% | 741 |
|
|
2021
Q4 | $2.13M | Buy |
8,300
+6,400
| +337% | +$1.57M | ﹤0.01% | 1065 |
|
|
2021
Q3 | $461K | Buy |
+1,900
| New | +$465K | ﹤0.01% | 1528 |
|
|
2021
Q1 | – | Sell |
-269,400
| Closed | -$44.3M | – | 1484 |
|
|
2020
Q4 | $44.3M | Sell |
269,400
-70,900
| -21% | -$10.4M | 0.04% | 320 |
|
|
2020
Q3 | $42.4M | Buy |
340,300
+115,600
| +51% | +$14.3M | 0.03% | 452 |
|
|
2020
Q2 | $21.8M | Buy |
224,700
+26,800
| +14% | +$2.79M | 0.03% | 495 |
|
|
2020
Q1 | $17.8M | Buy |
197,900
+153,000
| +341% | +$19.8M | 0.02% | 434 |
|
|
2019
Q4 | $6.64M | Buy |
+44,900
| New | +$6.03M | 0.01% | 794 |
|
|
2019
Q2 | – | Sell |
-1,500
| Closed | -$195K | – | 3036 |
|
|
2019
Q1 | $195K | Sell |
1,500
-4,600
| -75% | -$618K | ﹤0.01% | 1901 |
|
|
2018
Q4 | $758K | Buy |
+6,100
| New | +$819K | ﹤0.01% | 1398 |
|
|
2018
Q1 | – | Sell |
-550,000
| Closed | -$48.3M | – | 3063 |
|
|
2017
Q4 | $48.3M | Buy |
550,000
+250,000
| +83% | +$20.1M | 0.07% | 136 |
|
|
2017
Q3 | $23.9M | Hold |
300,000
| – | – | 0.04% | 227 |
|
|
2017
Q2 | $26.2M | Sell |
300,000
-502,300
| -63% | -$42.5M | 0.05% | 215 |
|
|
2017
Q1 | $71.4M | Buy |
802,300
+122,400
| +18% | +$10.2M | 0.15% | 89 |
|
|
2016
Q4 | $50.3M | Buy |
679,900
+29,900
| +5% | +$2.24M | 0.1% | 147 |
|
|
2016
Q3 | $49.2M | Buy |
650,000
+250,000
| +63% | +$19.1M | 0.09% | 140 |
|
|
2016
Q2 | $30.8M | Sell |
400,000
-1,200
| -0.3% | -$94.7K | 0.06% | 214 |
|
|
2016
Q1 | $31.3M | Buy |
+401,200
| New | +$28M | 0.07% | 180 |
|
|
2015
Q4 | – | Sell |
-200
| Closed | -$15K | – | 3284 |
|
|
2015
Q3 | $15K | Sell |
200
-49,800
| -100% | -$4.41M | ﹤0.01% | 2495 |
|
|
2015
Q2 | $4.54M | Sell |
50,000
-41,200
| -45% | -$3.3M | 0.01% | 746 |
|
|
2015
Q1 | $6.86M | Buy |
91,200
+35,900
| +65% | +$2.58M | 0.02% | 599 |
|
|
2014
Q4 | $4.06M | Sell |
55,300
-75,600
| -58% | -$5.31M | 0.01% | 770 |
|
|
2014
Q3 | $9.23M | Buy |
130,900
+128,400
| +5,136% | +$8.49M | 0.03% | 484 |
|
|
2014
Q2 | $142K | Sell |
2,500
-1,900
| -43% | -$100K | ﹤0.01% | 2240 |
|
|
2014
Q1 | $231K | Buy |
4,400
+2,400
| +120% | +$119K | ﹤0.01% | 1382 |
|
|
2013
Q4 | $97K | Sell |
2,000
-9,300
| -82% | -$430K | ﹤0.01% | 1848 |
|
|
2013
Q3 | $484K | Sell |
11,300
-2,500
| -18% | -$97.7K | ﹤0.01% | 836 |
|
|
2013
Q2 | $499K | Buy |
+13,800
| New | +$534K | ﹤0.01% | 832 |
|
Other funds holding HCA
VCM
VPM
Parallax Volatility Advisers's HCA Position: Q2 2025 in Review
Parallax Volatility Advisers sold out of HCA Healthcare (HCA) in Q2 2025, closing a stake of 2 shares — an estimated $721 sold.
Parallax Volatility Advisers first reported a position in HCA in Q2 2013 and held it in 28 quarters. The position peaked at $8.99M in Q2 2020. 1,248 funds tracked by Wall St. Rank hold HCA as of Q2 2025.
- Parallax Volatility Advisers reported no remaining HCA Healthcare position as of Q2 2025 after selling out during the quarter.
- Parallax Volatility Advisers sold 2 HCA Healthcare shares in Q2 2025, an estimated $721.
- Parallax Volatility Advisers first reported a position in HCA Healthcare in Q2 2013 and held it in 28 quarters.
- Parallax Volatility Advisers's HCA Healthcare position peaked at $8.99M in Q2 2020.
- 1,248 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2025.
Based on Parallax Volatility Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.